None listed
Conditions
Interventions
Ingest test-food A by dissolving it in liquid such as water, at breakfast every day for 4 weeks.
Ingest test-food B by dissolving it in liquid such as water, at breakfast every day for 4 weeks.
Ingest
Sponsors
Morinaga & CO., LTD.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1) Person who has a routine visit to Matsuike clinic "2) Women with mild constipation who are prescribed magnesium oxide at the age of 20 years old or more and under 60 years old at the time of obtaining informed consent for study participation" 3)Person whose BMI is over 30.0 kg/m^2 or 4)Person who do not take protein-enriched food(protein powder, protein bar, protein drink) during the examination period 5) Person who have be given sufficient explanation about the purpose and contents of this study, has the ability to agree, volunteer for voluntary participation with good understanding, and can consent to this examination in writing 6) Person who can come to Matsuike Clinic on the designated day and receive an interview 7) Person who were considered appropriate to participate in this study by the study doctor
Exclusion criteria
Exclusion criteria: 1) Person who have symptoms other than mild constipation 2) Person who have some factor that the examining physician can not judge the affect to the study 3) Person who have food allergies. 4) Person who regularly drink protein powder (manufacturer is not matter) 5) Person who plan pregnancy, lactation or pregnancy possibility and pregnancy during the study period 6) Person with alcoholism or other mental disorders 7) Person who may change lifestyle during the examination period (night work, long trips, etc.) 8) Person who are planning to take health functional food or supplement food during the test period 9) Person who received treatment with hospitalization within the past 6 months,or who are plannning to be hospitalized during the examination period 10) Person who are currently participating in other clinical trials, or person who have not passed three months after participating in other clinical trials 11) Person who the study doctor judged as inappropriate for this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Average number of defecation per week and Gut microbiota analysis,before ingestion and 4 weeks after ingestion. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)Defecation characteristics (defecation frequency, number of defecation, quantity, shape, incomplete evacuation, fecal odor) 2)Average number of tablets of the magnesium carbonate which ingested per week ,before ingestion and 4 weeks after ingestion. | — |
Countries
Japan
Contacts
Public ContactMisae Kawai
Morinaga & CO., LTD. R & D institute
Outcome results
None listed